Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Anti-Hcd70 Car Transduced Pbl
Breast Cancer
National Cancer Institute (NCI)
P1/2
CC
(40)
Anti-Hcd70 Car Transduced Pbl
Ovarian Cancer
National Cancer Institute (NCI)
P1/2
CC
(40)
Anti-Hcd70 Car Transduced Pbl
Pancreatic Neoplasm
National Cancer Institute (NCI)
P1/2
CC
(40)
h1299 cell lysates
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(40)
SX682
Prostate Cancer
National Cancer Institute (NCI)
P1/2
CC
(40)
Therapeutic Cancer Vaccine Genetically Modified To Express Recombinant Carcinoembryonic Antigen (Cea) Protein, Using Heat-Killed Yeast (Saccharomyces Cerevisiae) As A Vector
Colorectal Cancer
National Cancer Institute (NCI)
P1/2
CC
(40)
Autologous Ccr4 Car T Cells
Peripheral T-Cell Lymphoma, Not Otherwise Specified
National Cancer Institute (NCI)
P1
C
(39)
Cbx-12
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P1
C
(39)
Dordaviprone
Adenomatous Colon Polyp
National Cancer Institute (NCI)
P1
C
(39)
Dordaviprone
Classic Familial Adenomatous Polyposis
National Cancer Institute (NCI)
P1
C
(39)
Edodekin Alfa
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P1
C
(39)
Iadademstat
Acute Myeloid Leukemia
National Cancer Institute (NCI)
P1
C
(39)
Kras Tcr-Transduced Pbl
Breast Cancer
National Cancer Institute (NCI)
P1
C
(39)
pds01adc
Urinary Bladder Carcinoma
National Cancer Institute (NCI)
P1
C
(39)
Turalio
Sarcoma
National Cancer Institute (NCI)
P1
C
(39)
Autologous Hucd19 Car T Cells
Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P1/2
C
(39)
Sotorasib
Female Reproductive Organ Cancer
National Cancer Institute (NCI)
P2
C
(38)
Egfr/B7H3 Car-T
Neoplasm
National Cancer Institute (NCI)
P1
C
(38)
Fgfr4-Car T Cells
Rhabdomyosarcoma
National Cancer Institute (NCI)
P1
C
(38)
MDM2 INHIBITOR AMG-232
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)
P1
C
(38)
Revumenib
Acute Myeloid Leukemia With Mutated NPM1
National Cancer Institute (NCI)
P1
C
(38)
Vismodegib
Gastric Carcinoma
National Cancer Institute (NCI)
P2
C
(37)
Falimarev
Pancreatic Ductal Adenocarcinoma
National Cancer Institute (NCI)
P1
C
(37)
Hcv Dna Vaccine Ino-8000
Hepatocellular Carcinoma
National Cancer Institute (NCI)
P1
C
(37)
Inalimarev
Pancreatic Ductal Adenocarcinoma
National Cancer Institute (NCI)
P1
C
(37)
Showing 3176 to 3200 of 3,272 assets
Previous
Page 128 of 131
Next